Open call for applications for non-human primate TB vaccine testing

Tuberculosis (TB) remains an urgent global health problem with 1.4 million deaths per year. New vaccines will have a huge impact in combating the disease, including the growing threat of drug resistant TB. TBVI aims to contribute to the development of new TB vaccines by supporting research partners in universities, research institutes and private companies.